Company filings profile · CIK 0001253689
CRESCENT BIOPHARMA, INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for CRESCENT BIOPHARMA, INC. (CBIO): 21 filings in the last 90 days vs 29 in the prior 90 (filing-velocity cooling ↓ · 0.72×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 16, 2026. Source-linked, daily-refreshed.
Material 8-K events — CRESCENT BIOPHARMA, INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 15, 2026 | Other Events | ↗ |
| Jul 30, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Results of Operations (earnings) | ↗ |
Watch CRESCENT BIOPHARMA, INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 15, 2026 | 8-K | Other Events | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | S-8 | S-8 | ↗ |
| Sep 17, 2026 | 144 | ↗ | |
| Sep 17, 2026 | 144 | ↗ | |
| Sep 16, 2026 | 144 | ↗ | |
| Sep 16, 2026 | 144 | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 31, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 30, 2026 | POS AM | POS AM | ↗ |
| Jul 30, 2026 | 424B3 | 424B3 | ↗ |
| Jul 30, 2026 | 10-Q | 10-Q | ↗ |
| Jul 30, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A | ↗ | |
| Jul 20, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jul 15, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | 424B5 | 424B5 | ↗ |
| Jul 14, 2026 | 8-K | Results of Operations (earnings) | ↗ |
| Jul 14, 2026 | 424B5 | 424B5 | ↗ |
| Jul 10, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 1, 2026 | S-3 | S-3 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 23, 2026 | 4 | FORM 4 | ↗ |
| Jun 22, 2026 | 424B3 | 424B3 | ↗ |
| Jun 22, 2026 | 10-Q/A | 10-Q/A | ↗ |
| Jun 3, 2026 | 4 | FORM 4 | ↗ |
| Jun 3, 2026 | 4 | FORM 4 | ↗ |
| Jun 3, 2026 | 4 | FORM 4 | ↗ |
| Jun 3, 2026 | 4 | FORM 4 | ↗ |